3.6(top 10%)
impact factor
3.8K(top 5%)
papers
130.0K(top 5%)
citations
143(top 5%)
h-index
3.7(top 10%)
impact factor
4.3K
all documents
138.5K
doc citations
223(top 5%)
g-index

Top Articles

#TitleJournalYearCitations
1Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trialJournal of Psychopharmacology20161,221
2Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trialJournal of Psychopharmacology2016973
35-HT and mechanisms of defenceJournal of Psychopharmacology1991868
4Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept studyJournal of Psychopharmacology2015768
5Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for PsychopharmacologyJournal of Psychopharmacology2016755
6Human hallucinogen research: guidelines for safetyJournal of Psychopharmacology2008742
7Review: Suicide and schizophrenia: a systematic review of rates and risk factorsJournal of Psychopharmacology2010653
8Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of opennessJournal of Psychopharmacology2011641
9Conditioning factors in drug abuse: can they explain compulsion?Journal of Psychopharmacology1998630
10Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addictionJournal of Psychopharmacology2014613
11Glutamate and dopamine in schizophrenia: An update for the 21st centuryJournal of Psychopharmacology2015596
12Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months laterJournal of Psychopharmacology2008589
13Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for PsychopharmacologyJournal of Psychopharmacology2005537
14Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelinesJournal of Psychopharmacology2015528
15Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for PsychopharmacologyJournal of Psychopharmacology2014511
16Review: Inequalities in healthcare provision for people with severe mental illnessJournal of Psychopharmacology2010493
17The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot studyJournal of Psychopharmacology2011492
18British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disordersJournal of Psychopharmacology2010484
19Evidence-based guidelines for treating bipolar disorder: revised second edition—recommendations from the British Association for PsychopharmacologyJournal of Psychopharmacology2009451
20Asenapine: a novel psychopharmacologic agent with a unique human receptor signatureJournal of Psychopharmacology2009451
21Review: Mortality trends in the general population: the importance of cardiorespiratory fitnessJournal of Psychopharmacology2010451
22Dopamine as the wind of the psychotic fire: new evidence from brain imaging studiesJournal of Psychopharmacology1999446
23Serotonin and brain function: a tale of two receptorsJournal of Psychopharmacology2017440
24Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelinesJournal of Psychopharmacology2008437
25Amphetamine, past and present – a pharmacological and clinical perspectiveJournal of Psychopharmacology2013431
26Catecholamine regulation of the prefrontal cortexJournal of Psychopharmacology1997423
27Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trialsJournal of Psychopharmacology2012420
28Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary reportJournal of Psychopharmacology2011406
29The neural substrates of sensorimotor gating of the startle reflex: a review of recent findings and their implicationsJournal of Psychopharmacology1992403
30Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairmentJournal of Psychopharmacology2013373
31Evidence-Based Guidelines for Treating Bipolar Disorder: Recommendations from the British Association for PsychopharmacologyJournal of Psychopharmacology2003369
32Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelinesJournal of Psychopharmacology2000367
33Psychedelics and the essential importance of contextJournal of Psychopharmacology2018357
34Cannabis as a risk factor for psychosis: systematic reviewJournal of Psychopharmacology2005356
35Impulsivity: a discussion of clinical and experimental findingsJournal of Psychopharmacology1999347
36Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studiesJournal of Psychopharmacology2011346
37Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for PsychopharmacologyJournal of Psychopharmacology2011332
38NK1 (TACR1) receptor gene ‘knockout’ mouse phenotype predicts genetic association with ADHDJournal of Psychopharmacology2010329
39Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybinJournal of Psychopharmacology2015318
40LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effectsJournal of Psychopharmacology2015317
41Review: Glutamate and dopamine dysregulation in schizophrenia — a synthesis and selective reviewJournal of Psychopharmacology2007316
42The other face of depression, reduced positive affect: the role of catecholamines in causation and cureJournal of Psychopharmacology2007311
43Prolactin and dopamine: What is the connection? A Review ArticleJournal of Psychopharmacology2008310
44Treatment of depression: time to consider folic acid and vitamin B12Journal of Psychopharmacology2005309
45Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up studyJournal of Psychopharmacology2013306
46Suicide and schizophreniaJournal of Psychopharmacology2001303
47Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequencesJournal of Psychopharmacology2016303
48A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug useJournal of Psychopharmacology1998300
49Effects of ipsapirone and cannabidiol on human experimental anxietyJournal of Psychopharmacology1993298
50Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis usersJournal of Psychopharmacology2009294